| NANOVIRICIDES, INC. |
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 |
| Balance Sheet Date | | | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | | 2021-Sep-30 | | | | | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | 2013-Dec-31 |
| Fiscal Period | | | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | | Q1-FY2021 | | | | | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 |
| Operating Cash Flow | | | (1,701,906$) | (1,990,965$) | (2,190,945$) | (2,594,863$) | (1,481,336$) | (1,943,502$) | (1,718,975$) | (1,171,694$) | (1,498,584$) | (1,738,087$) | (1,400,522$) | (1,032,858$) | (1,397,704$) | | | (724,231$) | | | | | (1,708,368$) | (2,396,990$) | | (1,434,010$) | (1,671,983$) | (2,010,224$) | (2,158,411$) | (962,152$) | (3,519,449$) | (1,295,898$) | (1,403,733$) | (1,556,788$) | (1,009,266$) | (2,052,296$) | (2,611,361$) | (2,224,823$) | | | | | | | | | | | |
| Investing Cash Flow | | | (10,200$) | 0$ | 0$ | (46,764$) | (98,163$) | | (5,474$) | (8,291$) | (2,566$) | | | | | | | | | | | | | 0$ | | | | | | | | | | | | | | | | | | | | | | | | | |
| Financing Cash Flow | | | 728,080$ | 575,503$ | 2,282,708$ | 1,710,138$ | | | | | 0$ | 0$ | (23,837$) | (70,951$) | (32,709$) | | | (71,339$) | | | | | 9,315,931$ | 7,794,872$ | | (242,105$) | 0$ | 2,350,000$ | | | | | | | | | | | | | | | | | | | | | |
| End Cash Position | | | 1,558,564$ | 2,542,590$ | 3,958,052$ | 3,866,289$ | 4,797,778$ | 3,257,240$ | 5,245,374$ | 6,969,823$ | 8,149,808$ | 9,650,958$ | 11,448,346$ | 12,918,044$ | 14,066,359$ | 15,572,134$ | | 19,696,794$ | | | | | 13,708,594$ | 6,105,530$ | 707,648$ | 874,953$ | 2,555,207$ | 4,236,845$ | 3,903,672$ | 6,082,365$ | 7,081,771$ | 10,617,837$ | 12,046,400$ | 13,512,240$ | 15,099,461$ | 16,155,085$ | 19,301,566$ | 21,912,927$ | 24,162,185$ | 25,596,376$ | 28,237,621$ | 29,480,258$ | 31,467,748$ | 33,919,404$ | 35,258,618$ | 41,120,652$ | 36,696,892$ | 33,265,347$ | 16,948,832$ |
| Exchange Rate Effect | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Dividends Paid | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |